Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
2016 ◽
Vol 16
(1)
◽
pp. 43-52
◽
Keyword(s):
Phase 3
◽